Statement Of Cash Flows [Abstract]

Medicover - Filing #702771

Concept 2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
As at
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
As at
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
As at
2019-12-31
Statement of cash flows [abstract]
Cash flows from (used in) operating activities [abstract]
Profit (loss)
48,000,000 EUR
EUR
EUR
EUR
1,018,000,000 EUR
EUR
EUR
EUR
1,066,000,000 EUR
1,018,000,000 EUR
273,000,000 EUR
EUR
258,000,000 EUR
EUR
EUR
EUR
EUR
15,000,000 EUR
EUR
258,000,000 EUR
Adjustments to reconcile profit (loss) [abstract]
Adjustments for decrease (increase) in inventories
171,000,000 EUR
220,000,000 EUR
Adjustments for unrealised foreign exchange losses (gains)
26,000,000 EUR
70,000,000 EUR
Adjustments for share-based payments
64,000,000 EUR
47,000,000 EUR
Other adjustments for non-cash items
18,000,000 EUR
53,000,000 EUR
Income taxes paid (refund), classified as operating activities
183,000,000 EUR
110,000,000 EUR
Cash flows from (used in) operating activities
2,167,000,000 EUR
1,551,000,000 EUR
Cash flows from (used in) investing activities [abstract]
Cash flows used in obtaining control of subsidiaries or other businesses, classified as investing activities
875,000,000 EUR
122,000,000 EUR
Cash advances and loans made to other parties, classified as investing activities
28,000,000 EUR
2,000,000 EUR
Cash receipts from repayment of advances and loans made to other parties, classified as investing activities
EUR
1,000,000 EUR
Interest received, classified as investing activities
9,000,000 EUR
9,000,000 EUR
Other inflows (outflows) of cash, classified as investing activities
403,000,000 EUR
109,000,000 EUR
Cash flows from (used in) investing activities
3,336,000,000 EUR
1,263,000,000 EUR
Cash flows from (used in) financing activities [abstract]
Payments from changes in ownership interests in subsidiaries that do not result in loss of control
15,000,000 EUR
12,000,000 EUR
Proceeds from issuing shares
3,000,000 EUR
1,419,000,000 EUR
Payments to acquire or redeem entity's shares
3,000,000 EUR
EUR
Proceeds from borrowings, classified as financing activities
2,937,000,000 EUR
1,814,000,000 EUR
Repayments of borrowings, classified as financing activities
547,000,000 EUR
2,878,000,000 EUR
Payments of lease liabilities, classified as financing activities
385,000,000 EUR
314,000,000 EUR
Dividends paid, classified as financing activities
104,000,000 EUR
EUR
Interest paid, classified as financing activities
197,000,000 EUR
158,000,000 EUR
Cash flows from (used in) financing activities
1,641,000,000 EUR
132,000,000 EUR
Increase (decrease) in cash and cash equivalents before effect of exchange rate changes
472,000,000 EUR
156,000,000 EUR
Effect of exchange rate changes on cash and cash equivalents [abstract]
Effect of exchange rate changes on cash and cash equivalents
120,000,000 EUR
37,000,000 EUR
Increase (decrease) in cash and cash equivalents after effect of exchange rate changes
472,000,000 EUR
156,000,000 EUR
Cash and cash equivalents
819,000,000 EUR
467,000,000 EUR
348,000,000 EUR

Talk to a Data Expert

Have a question? We'll get back to you promptly.